Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA NATCO PHARMA JUBILANT PHARMOVA /
NATCO PHARMA
 
P/E (TTM) x -2,647.7 13.3 - View Chart
P/BV x 1.7 3.5 48.0% View Chart
Dividend Yield % 0.9 0.6 152.2%  

Financials

 JUBILANT PHARMOVA    NATCO PHARMA
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
NATCO PHARMA
Mar-23
JUBILANT PHARMOVA /
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs496847 58.5%   
Low Rs269502 53.5%   
Sales per share (Unadj.) Rs394.4148.4 265.8%  
Earnings per share (Unadj.) Rs-4.139.2 -10.4%  
Cash flow per share (Unadj.) Rs30.748.2 63.7%  
Dividends per share (Unadj.) Rs5.005.50 90.9%  
Avg Dividend yield %1.30.8 160.4%  
Book value per share (Unadj.) Rs338.6267.1 126.8%  
Shares outstanding (eoy) m159.28182.47 87.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.04.5 21.3%   
Avg P/E ratio x-93.817.2 -545.4%  
P/CF ratio (eoy) x12.414.0 88.9%  
Price / Book Value ratio x1.12.5 44.7%  
Dividend payout %-122.714.0 -874.9%   
Avg Mkt Cap Rs m60,873123,049 49.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,6604,867 445.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,81727,071 232.0%  
Other income Rs m3831,285 29.8%   
Total revenues Rs m63,20128,356 222.9%   
Gross profit Rs m7,3179,117 80.3%  
Depreciation Rs m5,5401,638 338.2%   
Interest Rs m1,882145 1,297.9%   
Profit before tax Rs m2788,619 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9271,466 63.2%   
Profit after tax Rs m-6497,153 -9.1%  
Gross profit margin %11.633.7 34.6%  
Effective tax rate %333.517.0 1,961.0%   
Net profit margin %-1.026.4 -3.9%  
BALANCE SHEET DATA
Current assets Rs m37,62430,003 125.4%   
Current liabilities Rs m17,7246,831 259.5%   
Net working cap to sales %31.785.6 37.0%  
Current ratio x2.14.4 48.3%  
Inventory Days Days2563 38.6%  
Debtors Days Days56115 48.4%  
Net fixed assets Rs m71,66826,571 269.7%   
Share capital Rs m159365 43.6%   
"Free" reserves Rs m53,77248,373 111.2%   
Net worth Rs m53,93148,738 110.7%   
Long term debt Rs m31,1040-   
Total assets Rs m109,29256,574 193.2%  
Interest coverage x1.160.4 1.9%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.60.5 120.1%   
Return on assets %1.112.9 8.7%  
Return on equity %-1.214.7 -8.2%  
Return on capital %2.518.0 14.1%  
Exports to sales %00-   
Imports to sales %4.110.2 39.9%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,5642,772 92.5%   
Fx inflow Rs m7,10017,256 41.1%   
Fx outflow Rs m2,5642,772 92.5%   
Net fx Rs m4,53614,484 31.3%   
CASH FLOW
From Operations Rs m6,6078,491 77.8%  
From Investments Rs m-5,444-4,771 114.1%  
From Financial Activity Rs m-1,567-3,630 43.2%  
Net Cashflow Rs m301208 144.7%  

Share Holding

Indian Promoters % 47.4 49.7 95.3%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 25.0 92.8%  
FIIs % 20.3 13.7 147.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 50.3 98.1%  
Shareholders   86,588 207,571 41.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Jubilant Pharmova vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Natco Pharma Share Price Performance

Period Jubilant Pharmova Natco Pharma S&P BSE HEALTHCARE
1-Day -0.54% -2.11% 1.18%
1-Month 2.20% -3.19% -0.75%
1-Year 109.28% 72.80% 61.82%
3-Year CAGR -6.79% 4.96% 18.16%
5-Year CAGR -2.78% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.